• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation.

作者信息

Kawamoto Hiroyoshi, Panoulas Vasileios F, Sato Katsumasa, Miyazaki Tadashi, Naganuma Toru, Sticchi Alessandro, Latib Azeem, Colombo Antonio

机构信息

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; National Heart and Lung Institute, Imperial College London, London, UK; New Tokyo Hospital, Chiba, Japan.

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy; National Heart and Lung Institute, Imperial College London, London, UK; New Tokyo Hospital, Chiba, Japan.

出版信息

Int J Cardiol. 2014 Dec 15;177(2):607-9. doi: 10.1016/j.ijcard.2014.09.039. Epub 2014 Sep 28.

DOI:10.1016/j.ijcard.2014.09.039
PMID:25443250
Abstract
摘要

相似文献

1
Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation.
Int J Cardiol. 2014 Dec 15;177(2):607-9. doi: 10.1016/j.ijcard.2014.09.039. Epub 2014 Sep 28.
2
Long-term favorable coronary healing after bioresorbable scaffold implantation: insights from OCT.生物可吸收支架植入术后长期良好的冠状动脉愈合：光学相干断层扫描的见解
J Am Coll Cardiol. 2014 Dec 9;64(22):2357-9. doi: 10.1016/j.jacc.2014.07.996. Epub 2014 Dec 1.
3
OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold.经皮冠状动脉介入治疗后 5 年的依维莫司洗脱生物可吸收血管支架的长期血管愈合反应的 OCT 评估。
J Am Coll Cardiol. 2014 Dec 9;64(22):2343-56. doi: 10.1016/j.jacc.2014.09.029. Epub 2014 Dec 1.
4
"Full-plastic jacket" with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413).载有依维莫司的可完全吸收聚合物涂层 Absorb 生物可吸收血管支架的临床结果：多中心前瞻性 RAI 注册研究（ClinicalTrials.gov 标识符：NCT02298413）。
Int J Cardiol. 2018 Sep 1;266:67-74. doi: 10.1016/j.ijcard.2018.01.063.
5
Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives.依维莫司洗脱 ABSORB 生物可吸收血管支架：现状与未来展望。
Expert Rev Med Devices. 2012 Jul;9(4):327-38. doi: 10.1586/erd.12.17. Epub 2012 Mar 16.
6
Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds.依维莫司洗脱支架和生物可吸收血管支架内冠状动脉瘤的形成。
Int J Cardiol. 2016 Mar 1;206:58-60. doi: 10.1016/j.ijcard.2016.01.091. Epub 2016 Jan 7.
7
Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment.ABSORB生物可吸收依维莫司洗脱血管支架系统的五年随访：多模态成像评估
EuroIntervention. 2013 Feb 22;8(10):1126-7. doi: 10.4244/EIJV8I10A187.
8
Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion.依维莫司洗脱生物可吸收血管支架用于慢性完全闭塞患者的可行性
Int J Cardiol. 2015 Jan 20;179:90-4. doi: 10.1016/j.ijcard.2014.10.032. Epub 2014 Nov 7.
9
1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.依维莫司洗脱生物可吸收血管支架治疗糖尿病患者 1 年的临床结果：ABSORB 和 SPIRIT 试验的汇总分析。
JACC Cardiovasc Interv. 2014 May;7(5):482-93. doi: 10.1016/j.jcin.2014.01.155. Epub 2014 Apr 16.
10
First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography.依维莫司洗脱生物可吸收血管支架植入治疗药物洗脱支架失败的首例人体描述：光学相干断层扫描的见解
Int J Cardiol. 2013 Oct;168(4):4490-1. doi: 10.1016/j.ijcard.2013.06.127. Epub 2013 Jul 24.

引用本文的文献

1
Bioresorbable scaffolds and drug-eluting balloons for the management of spontaneous coronary artery dissections.用于治疗自发性冠状动脉夹层的生物可吸收支架和药物洗脱球囊。
J Thorac Dis. 2016 Oct;8(10):E1328-E1330. doi: 10.21037/jtd.2016.10.54.
2
Bioresorbable vascular scaffolds technology: current use and future developments.生物可吸收血管支架技术：当前应用与未来发展
Med Devices (Auckl). 2016 Jul 11;9:185-98. doi: 10.2147/MDER.S90461. eCollection 2016.